No abstract available
MeSH terms
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / supply & distribution
-
Betacoronavirus
-
COVID-19
-
Chloroquine / supply & distribution
-
Coronavirus Infections / epidemiology*
-
Coronavirus Infections / immunology
-
Delivery of Health Care / methods*
-
Developing Countries*
-
Humans
-
Hydroxychloroquine / supply & distribution
-
Immunocompromised Host
-
Pandemics
-
Pneumonia, Viral / epidemiology*
-
Pneumonia, Viral / immunology
-
Rheumatic Diseases / drug therapy
-
Rheumatic Diseases / immunology
-
SARS-CoV-2
-
Telemedicine
Substances
-
Antirheumatic Agents
-
Hydroxychloroquine
-
Chloroquine